An observational study in Pituitary Diseases and Pituitary Neoplasms, sponsored by University of Alberta. Active, not recruiting. Per ClinicalTrials.gov, last updated 2026-03-16.
Sponsored by University of Alberta · Observational
To determine the outcomes of patients with different pituitary disorders whether they are managed medically, surgically or expectantly.
A chart audit of around 1500 patients seen in two specific clinics, the Medical Pituitary Clinic and the combined Endocrine/Neurosurgical Pituitary Clinic at the University of Alberta Hospital, will be performed to determine the effectiveness of various treatment strategies on the long term outcome of specific pituitary disorders. The investigator's will collect retrospective demographic (age, sex, ethnicity), clinical (mode of presentation, hormonal parameters) and therapeutic outcome (surgical, medical, expectant and / or radiation treatment; co-morbidities and complications) of patients seen in these two clinics between January 2000 and December 2020.
200 studies on the registry are indexed under Pituitary Neoplasms; 51 are open to participants now.
This study's planned enrollment of 1,500 is above the median of 163 across 74 observational studies indexed under Pituitary Neoplasms.
Browse Pituitary Neoplasms studies →University of Alberta is the lead sponsor of 823 studies on the registry; 169 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 3 (60%) have results posted.
Compared within Pituitary Neoplasms, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Pituitary Diseases. The counts are of registry records indexed under each term, refreshed daily. How we classify →
tertiary referral center
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Progression free survival after pituitary surgery
Using clinical, biochemical and imaging studies of a cohort of surgically operated patients to identify prognostic factors of tumor recurrence
Time frame: up to 17 years post surgery
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
Started Jan 2000 (actual). Primary completion is estimated for Dec 2026, 323 months after the start.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.